1961
DOI: 10.1128/aem.9.4.334-336.1961
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Paper on the Performance Assay in the Control of Antibiotic Sensitivity Discs

Abstract: KRAMER, JULIAN (Food and Drug Administration, Washington, D. C.), AND AMIEL KIRSHBAUM. Effect of paper on the performance assay in the control of antibiotic sensitivity discs. Appl. Microbiol. 9:334-336. 1961.-Antibiotic discs were prepared, using several several batches of papers meeting Food and Drug Administration specifications. The analysis of 1,152 zones of inhibition produced showed no performance differences among these batches. Other discs were prepared using papers of different grades. These produced… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1978
1978
2020
2020

Publication Types

Select...
2
1
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Antimicrobial susceptibility testing was performed on Mueller-Hinton Agar (Hi-media) plates with sterilized dry filter paper disc 5 loaded with different quantum of the antibiotics ranging from 5 to 0.02 µg by the Kirby-Bauer disc diffusion method.…”
Section: Antimicrobial Susceptibility Testingmentioning
confidence: 99%
See 1 more Smart Citation
“…Antimicrobial susceptibility testing was performed on Mueller-Hinton Agar (Hi-media) plates with sterilized dry filter paper disc 5 loaded with different quantum of the antibiotics ranging from 5 to 0.02 µg by the Kirby-Bauer disc diffusion method.…”
Section: Antimicrobial Susceptibility Testingmentioning
confidence: 99%
“…It is reasonable to expect that all the drugs contain the same salt and quantity. Thus, a clinician prescribes the medicine with its trade name only 5 .…”
Section: Introductionmentioning
confidence: 99%
“…Due to increased incidences of microbial infections and rising microbial resistance to antibiotics, innovative antimicrobial agents are the need of the present age. [1][2][3] Metal nanoparticles (NPs) exhibit significant antimicrobial activity by themselves [4][5][6] as well as a synergistic activity when combined with other antimicrobial agents, 7,8 however, their utility is restricted due to their inherent instability leading to agglomeration and thus a reduction in potency. Furthermore, at high concentrations their cytotoxic effects outstrip the antimicrobial potential.…”
Section: Introductionmentioning
confidence: 99%